StockWatch
·
Biotechnology: Pharmaceutical Preparations
RegulatoryJun 1, 2026, 04:00 PM

Exicure Regains Nasdaq Compliance After Delayed 10-Q Filing

AI Summary

Exicure, Inc. announced it received a Nasdaq non-compliance notification on May 28, 2026, for the delayed filing of its Quarterly Report on Form 10-Q for the three months ended March 31, 2026. The delay was primarily due to changes in the company's financial reporting personnel and related filing procedures. Exicure subsequently filed the Form 10-Q on May 29, 2026, and believes it has regained compliance with Nasdaq Listing Rule 5250(c)(1).

Key Highlights

  • Received Nasdaq non-compliance notification on May 28, 2026.
  • Violated Nasdaq Listing Rule 5250(c)(1) due to delayed Q1 2026 Form 10-Q filing.
  • Delay caused by changes in financial reporting personnel and procedures.
  • Filed Quarterly Report on Form 10-Q on May 29, 2026.
  • Company believes it has regained compliance with Nasdaq listing rules.